| Literature DB >> 25631453 |
Martino Belvederi Murri1, Matteo Respino2, Marco Innamorati3, Alice Cervetti2, Pietro Calcagno2, Maurizio Pompili4, Dorian A Lamis5, Lucio Ghio2, Mario Amore2.
Abstract
Among patients with schizophrenia, better insight may be associated with depression, but the findings on this issue are mixed. We examined the association between insight and depression in schizophrenia by conducting a systematic review and meta-analysis. The meta-analysis was based on 59 correlational studies and showed that global clinical insight was associated weakly, but significantly with depression (effect size r=0.14), as were the insight into the mental disorder (r=0.14), insight into symptoms (r=0.14), and symptoms' attributions (r=0.17). Conversely, neither insight into the social consequences of the disorder nor into the need for treatment was associated with symptoms of depression. Better cognitive insight was significantly associated with higher levels of depression. The exploratory meta-regression showed that methodological factors (e.g. the instrument used to assess depression and the phase of the illness) can significantly influence the magnitude of the association between insight and depression. Moreover, results from longitudinal studies suggest that the relation between insight and depression might be stronger than what is observed at the cross-sectional level. Finally, internalized stigma, illness perception, recovery attitudes, ruminative style, and premorbid adjustment seem to be relevant moderators and/or mediators of the association between insight and depression. In conclusion, literature indicates that among patients with schizophrenia, better insight is associated with higher levels of depressive symptoms. Thus, interventions aimed at promoting patients' insight should take into account the clinical implications of these findings.Entities:
Keywords: Awareness of illness; Demoralization; Depression; Insight; Schizophrenia; Stigma
Mesh:
Year: 2015 PMID: 25631453 DOI: 10.1016/j.schres.2015.01.003
Source DB: PubMed Journal: Schizophr Res ISSN: 0920-9964 Impact factor: 4.939